ProfileGDS5822 / ILMN_1246271
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 3% 8% 25% 5% 4% 8% 18% 20% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 16.43
GSM1276600PDAC Late Ablation Control 2118
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 112.325
GSM1276603PDAC Late Ablation 26.25
GSM1276604PDAC Late Ablation 34.74
GSM1303940PDAC Late Ablation_anti-CTLA4 18.78
GSM1303941PDAC Late Ablation_anti-CTLA4 210.218
GSM1303942PDAC Late Ablation_anti-CTLA4 310.420